Earlier this month we wrote that Planned Parenthood was dropping its legal challenge in the federal Eighth Circuit Court of Appeals over the Abortion-Inducing Drugs Safety Act.
This 2015 law requires abortionists who perform chemical abortions to follow FDA protocols, and it requires abortion facilities that offer abortion drugs like RU-486 to contract with a doctor who has hospital admitting privileges to handle any complications arising from the abortion.
Requiring abortionists to follow FDA protocols may not sound like much, but it prevents abortion doctors from giving women abortion drugs later in pregnancy than the FDA recommends, which saves the lives of those unborn children.
After three years of wrangling in court, Planned Parenthood announced a few weeks ago that it would comply with the law even though it still thinks the law is unconstitutional.
Today the Arkansas Democrat-Gazette reports that Planned Parenthood has filed a request with U.S. District Judge Kristine Baker to put its lawsuit on hold for at least six months, but let Planned Parenthood renew its lawsuit against the state in the future if it so desires, writing,
Planned Parenthood asked Monday that a federal judge put a six-month hold on its lawsuit challenging a state law affecting medication abortions or let the case be dismissed under a provision allowing it to be refiled if necessary. . . .
In a filing Monday, Planned Parenthood attorneys said they want to submit a status report at the end of a six-month period, so Baker “can determine whether to extend the stay or dismiss the case without prejudice,” which would allow the case to be refiled.
In other words, it sounds like Planned Parenthood is going to comply with the law for now, but they want to keep their options open.
This is still a pro-life victory. The Abortion-Inducing Drugs Safety Act is going to be enforced as intended, and even if Planned Parenthood were to re-file its lawsuit against the state in the future, I believe Arkansas would win the case.
Photo Credit: By jordanuhl7 [CC BY 2.0 (http://creativecommons.org/licenses/by/2.0)], via Wikimedia Commons